"Clinresco Centres is a clinical research company that strives to provide service excellence to sponsoring pharmaceutical companies when conducting clinical research studies. We conduct clinical trials in South Africa according to approved protocols, International Conference on Harmonization-Good Clinical Practice (ICH-GCP), and South African-GCP guidelines."

During the past decade, Clinresco Centres (Pty) Ltd conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 8 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinresco Centres (Pty) Ltd" #1 sponsor was "Pfizer" with 4 trials, followed by "Advanz Pharma" with 1 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored, "Debiopharm International SA" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinresco Centres (Pty) Ltd" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Molecular Partners AG" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Clinresco Centres (Pty) Ltd" are "Rheumatoid Arthritis" (2 trials), "Arthritis" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Atrial Fibrillation" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Clinresco Centres (Pty) Ltd" in a lesser frequency.

Most popular intervention types in "Clinresco Centres (Pty) Ltd" are "Drug" (10 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "0 mg Induction ONLY" (1 trials), "150 mg Induction/Chronic" (1 trials), "40 mg Laninamivir Octanoate" (1 trials) and "450 mg Induction/Chronic" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinresco Centres (Pty) Ltd" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinresco Centres (Pty) Ltd". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Clinresco Centres (Pty) Ltd, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinresco Centres (Pty) Ltd, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".